Metall Zug Ag Class B · SIX:METN
Metall Zug Ag Class B — FY2024 Earnings Presentation
41 slides from Metall Zug Ag Class B's earnings presentation, Mar 24, 2025
Slide 1: Investor & Media Presentation Metall Zug AG - Welcome
Investor & Media Presentation Metall Zug AG - Welcome March 24, 2025 Martin Wipfli, Chairman of the Board Matthias Rey, CEO Urs Scherrer, CFO
Slide 2: Content
METALL ZUG GROUP Content 1. Group Financial Report 2. Business Units − Medical Devices − Technologycluster & Infrastructure − Investments & Corporate 3. Conclusions 4. Sustainability Investor & Media Presentation - March 24, 2025 2
Slide 3: What we have planned and what we achieved 2024
METALL ZUG GROUP What we have planned and what we achieved 2024 − Increase sales with a focus on US and Asian markets − Review the implementation of strategic initiatives − R&D push: Further development of microscopy (analogue and digital), digitalization of devices and product updates − Successful
Slide 4: Group Financial Report FY 2024
Group Financial Report FY 2024 Metall Zug Group Investor & Media Presentation - March 24, 2025 Medical Devices Technologycluster & Investments & Corporate Infrastructure
Slide 5: Income Statement
METALL ZUG GROUP Income Statement Metall Zug Group 2024 in % 2023 in % Comment (in CHF million) Net sales 283.4 100.0 494.7 100.0 Cost of Goods and Services sold -192.5 -67.9 -343.7 -69.5 Gross Profit 90.9 32.1 151.0 30.5 Marketing and sales expenses -41.2 -14.5 -56.7 -11.5 Research and development
Slide 6: Strategic Investments
METALL ZUG GROUP Strategic Investments Metall Zug Group Komax Group V-ZUG Group SteelcoBelimed Total (in CHF million) 2024 attributable result -4.1 5.7 1.5 3.1 - thereof current year pro rata net result -0.8 6.5 1.5 7.2 - thereof adjustment previous year's actual result -3.3 -0.8 0.0 -4.1 Book value
Slide 7: Net Sales FY 24
Net Sales FY 24 by Business Unit by region 17% 15% (15%) 17% (24%) (17%) 59% 24% (38%) (38%) 35% (35%) 33% (33%) Medical Devices Switzerland Infection Control Europe w/o Switzerland Investments & Corporate Americas Asia/Pacific/Others (Previous year’s values in brackets) Investor & Media Presentatio
Slide 8: Net Sales Analysis
METALL ZUG GROUP Net Sales Analysis 600.0 550.0 500.0 494.7 -166.4 450.0 in CHF million 400.0 350.0 -3.9 -14.0 300.0 -19.4 -3.1 -8.8 283.4 4.4 250.0 200.0 494.7 -166.4 -3.9 -14.0 -19.4 -3.1 -8.8 4.4 283.4 Net sales Deconsolidation FX Investments & Technologycluster Infection Control Medical Devices
Slide 9: Operating Result (EBIT) Analysis
METALL ZUG GROUP Operating Result (EBIT) Analysis 140.0 120.0 66.6 -21.7 100.0 -2.3 80.0 in CHF million -0.5 -14.1 60.0 -0.1 58.0 40.0 30.1 20.0 0.0 30.1 66.6 -21.7 -2.3 -0.5 -14.1 -0.1 58.0 EBIT Gain SteelcoBelimed Investments & Technologycluster & Infection Control Medical Devices IC-Elimination E
Slide 10: Balance Sheet
METALL ZUG GROUP Balance Sheet Metall Zug Group 12/31/2024 in % 12/31/2023 in % Comment (in CHF million) Cash and cash equivalents / securities 17.2 2.7 29.8 4.3 Other current assets 112.3 17.7 206.9 30.0 Current assets 129.5 20.5 236.7 34.4 Tangible assets 168.7 26.6 169.6 24.6 2024 includes strate
Slide 11: Cash Flow Statement
METALL ZUG GROUP Cash Flow Statement Metall Zug Group 2024 2023 Comment (in CHF million) Cash flow from operating activities 2.8 9.5 Cash flow from investing activities -53.5 -16.4 - of which investments in tangible assets -32.6 -35.5 - of which investments in intangible assets -1.3 -0.7 2023: Defer
Slide 12: Business Units
Business Units Metall Zug Group Investor & Media Presentation - March 24, 2025 Medical Devices Technologycluster & Investments & Corporate Infrastructure
Slide 13: Medical Devices
Medical Devices Medical Devices Investor & Media Presentation - March 24, 2025
Slide 14: Key figures
MEDICAL DEVICES Key figures 2024 2023 2022 2021 2020 (in CHF million) Net sales 167.6 178.3 225.6 215.2 169.6 Net sales developtment in % -6.0 -20.9 4.8 26.9 -17.2 of which foreign currency impact in % -1.1 -2.8 -0.6 -0.3 -3.0 of which acquisition & divestment impact in % 0.0 -4.0 -3.2 2.5 3.6 Organ
Slide 15: Key topics
MEDICAL DEVICES Key topics Highlights Net sales by product area − Launch of IM 910 – 3 D imaging module in % − Market launch of new innovative surgical microscope Metis − Order intake in “General Diagnostic” and “Chairs & Stands” 14% (11%) recorded growth, especially in key US marked − Overall order
Slide 16: Technologycluster & Infrastructure
Technologycluster & Infrastructure Investor & Media Presentation - March 24, 2025
Slide 17: Key figures
TECHNOLOGYCLUSTER & INFRASTRUCTURE Key figures 2024 2023 2022 2021 2020 (in CHF million) Net sales 0.1 19.6 0.0 0.0 0.0 Other operating income 13.3 12.6 12.7 12.0 15.8 Operating income (EBIT) 2.9 5.2 2.9 2.5 5.2 Employees (FTE) 31.0 30.0 26.0 22.0 22.0 CAPEX Total Rental income (in CHF million, Cash
Slide 18: Site overview
TECHNOLOGYCLUSTER & INFRASTRUCTURE Site overview Investor & Media Presentation - March 24, 2025 18
Slide 19: Main projects
TECHNOLOGYCLUSTER & INFRASTRUCTURE Main projects Highlights Building Volume − Development of real estate projects according to plan in m3 − Foundation stone of SHL Südtor officially laid in a ceremony 204’235 on May 23, 2024 Planned − Electorate of Zug city approved development plan GIBZ - wooden hi
Slide 20: Investments & Corporate
Investments & Corporate Investor & Media Presentation - March 24, 2025
Slide 21: Key figures
INVESTMENTS & CORPORATE Key figures 2024 2023 2022 2021 2020 (in CHF million) Net sales 49.1 117.3 86.2 68.4 75.6 Net sales developtment in % -58.1 36.1 26.1 -9.5 -0.6 of which foreign currency impact in % -0.1 -1.3 0.5 0.0 -0.3 of which acquisition & divestment impact in % -46.1 0.0 0.0 0.0 0.0 Org
Slide 22: Key topics
INVESTMENTS & CORPORATE Key topics − Successfully launched new „Ariane“ dishwasher range („Swiss made“) − Has invested in market development and operational excellence − Net Sales CHF 33.7 million (2023: CHF 35.4 million), but negative EBIT Investor & Media Presentation - March 24, 2025 22
Slide 23: Conclusions
Conclusions We create sustainable value through innovative solutions and a forward- looking investment policy. Investor & Media Presentation - March 24, 2025 Medical Devices Technologycluster & Investments & Corporate Infrastructure
Slide 24: Medical Devices
Medical Devices Haag-Streit is the number 1 in ophthalmic slit lamps. The global med tech company develops, produces and distributes innovative and premium devices and solutions for diagnostics in ophthalmology. Medical Devices Investor & Media Presentation - March 24, 2025
Slide 25: R&D expenses peak
MEDICAL DEVICES R&D expenses peak In CHF million 250 25.0% 22.7% 22.6% 22.7% 225.6 215.2 200 20.0% 178.3 169.6 167.6 17.0% 150 15.0% 100 10.0% 9.5% 48.9 51.5 50 40.3 5.0% 24.3 25.1 27.3 28.4 20.5 22.7 16.1 0 0.0% 2020 2021 2022 2023 2024 Net Sales Total R&D expenses EBIT before R&D EBIT before R&D i
Slide 26: Growth in product portfolio
MEDICAL DEVICES Growth in product portfolio Strategic Initiative Microscope − Expand and diversify our portfolio of products and solutions with a fully stacked R&D pipeline, building on our Refractor leading diagnostic expertise. Slit lamp Add-on Microscope (I) Key focus areas Add-on Microscope (II)
Slide 27: Technologycluster & Infrastructure
Technologycluster & Infrastructure Through the Tech Cluster Zug, Metall Zug is developing the original main site of V-ZUG with the aim of creating a sustainable and innovative technology cluster in the north of the city of Zug. Investor & Media Presentation - March 24, 2025
Slide 28: Capex outlook 2025-2032
TECHNOLOGYCLUSTER & INFRASTRUCTURE Capex outlook 2025-2032 Total CAPEX, cash flow view (in CHF million) 2025 2026 2027 2028 2029 2030 2031 2032 150.0 100.0 66.4 63.2 46.8 49.8 45.0 -12.2 39.6 50.0 -19.4 35.7 -8.3 -22.7 -17.6 54.2 43.8 -42.9 -23.7 51.2 41.5 24.1 22.0 12.0 0.0 2.1 -17.8 -50.0 -69.0 CA
Slide 29: Rental income outlook 2025-2032
TECHNOLOGYCLUSTER & INFRASTRUCTURE Rental income outlook 2025-2032 Target net return in CHF million − 3% taking into account investments in 20.0 19.0 18.9 infra-structure and market value of the 18.0 land. 16.0 13.7 14.1 Target rental income 14.0 12.3 12.3 − Office space: 320-400 CHF/m2 p.a. 12.0 11
Slide 30: Investments & Corporate
Investments & Corporate Due to our heritage as an industrial conglomerate, we hold a portfolio of strong strategic investments in Swiss industrial champions Investor & Media Presentation - March 24, 2025
Slide 31: Strategic investments
INVESTMENTS & CORPORATE Strategic investments − V-ZUG: − Komax: − Number 1 brand in Switzerland for household appliances − Number 1 in the global market for wire processing in kitchen and laundry with an international growth focusing on markets in the field of automation, listed on strategy, listed
Slide 32: Strategic investments
INVESTMENTS & CORPORATE Strategic investments − SteelcoBelimed: − Number 3 supplier for cleaning, sterilization and disinfection solutions for medical and surgical instruments (hospitals and pharmaceutical companies). − Has successfully commenced operations and the post-merger integration phase is p
Slide 33: Sustainability
Sustainability With targeted investments in energy efficiency, responsible procurement and social responsibility, we are actively shaping the future - for a sustainable economy and society. Investor & Media Presentation - March 24, 2025
Slide 34: Sustainability targets
SUSTAINABILITY Sustainability targets Investor & Media Presentation - March 24, 2025 34
Slide 35: Greenhouse Gas Fund
SUSTAINABILITY Greenhouse Gas Fund Goals: 1. Allocating a price to CO2 emissions 2. Metall Zug’s production sites in Switzerland are being CO 2 offset 3. Support the development and implementation of internal greenhouse gas-reducing innovation projects Financed Projects − Since implementation, the M
Slide 36: CO2 reduction path
SUSTAINABILITY CO2 reduction path Investor & Media Presentation - March 24, 2025 36
Slide 37: What we plan for 2025
METALL ZUG GROUP What we plan for 2025 − Product launches and further R&D push, digitalization of devices and product updates − Increase sales with a focus on US and Asian markets − Review the implementation of strategic initiatives − Obtaining building permit for CreaTower I − Develop interim use c
Slide 38: Information for Investors Metall Zug Group
Information for Investors Metall Zug Group Investor & Media Presentation - March 24, 2025
Slide 39: Financial calendar
METALL ZUG GROUP Financial calendar May 9, 2025 Ordinary Annual General Meeting of Shareholders 2025 (the invitation and the summary report will be sent out mid-April) May 15, 2025 Dividend Payment August 25, 2025 Publication of Half-year Report Investor & Media Presentation - March 24, 2025 39
Slide 40: Contact
METALL ZUG GROUP Contact Urs Scherrer CFO Bettine Killmer Head of Corporate Communications & Investor Relations Metall Zug AG Industriestrasse 66 (postal address), Grienbachstrasse 11 (office address) 6302 Zug Switzerland investorrelations@metallzug.ch Phone: +41 58 768 60 50 Investor & Media Presen
Slide 41: Disclaimer
METALL ZUG GROUP Disclaimer Metall Zug AG has made great efforts to include accurate and up-to-date information in this document. However, we make no representations or warranties, expressed or implied, as to the accuracy or completeness of the information provided in this document and disclaim any